ARCHIVES

NIH Reconsiders Closing A Meeting Of Advisory Group

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997